Showing results (91-100 of 138) with videos related to

Sort By:
Pageof 14
Journal of Clinical Medicine|September 23, 2022
The Potential Impact of Heparanase Activity and Endothelial Damage in COVID-19 DiseaseElisabeth Zechendorf, Katharina Schröder, Lara Stiehler, et al.
European Journal of Trauma and Emergency Surgery : Official Publication of the European Trauma Society|June 11, 2021
Standardized porcine unilateral femoral nailing is associated with changes in PMN activation status, rather than aberrant systemic PMN prevalenceMichel Paul Johan Teuben, Roman Pfeifer, Klemens Horst, et al.
Scientific Reports|March 8, 2017
Integrative Diffusion-Weighted Imaging and Radiogenomic Network Analysis of Glioblastoma multiformeDieter Henrik Heiland, Carl Philipp Simon-Gabriel, Theo Demerath, et al.
Pharmaceutics|September 28, 2021
Similar Piperacillin/Tazobactam Target Attainment in Obese versus Nonobese Patients despite Differences in Interstitial Tissue Fluid PharmacokineticsDavid Busse, Philipp Simon, David Petroff, et al.
The Journal of Antimicrobial Chemotherapy|May 16, 2019
Plasma and tissue pharmacokinetics of fosfomycin in morbidly obese and non-obese surgical patients: a controlled clinical trialChristoph Dorn, David Petroff, Nancy Neumann, et al.
Genes|November 27, 2024
Deciphering Carotenoid and Flowering Pathway Gene Variations in Eastern and Western Carrots (Daucus carota L.)Sarvamangala S Cholin, Chaitra C Kulkarni, Dariusz Grzebelus, et al.
Scientific Reports|July 1, 2024
Ribonuclease inhibitor 1 emerges as a potential biomarker and modulates inflammation and iron homeostasis in sepsisCarolina Neu, Christian Beckers, Nadine Frank, et al.
Journal of Critical Care|May 10, 2026
How does the prioritisation of care affect ICU healthcare professionals?Emilio Rodriguez-Ruiz, Anja Hohenwallner, Kristina Fuest, et al.
Biomolecules|August 16, 2020
Targeting Endothelial Dysfunction in Eight Extreme-Critically Ill Patients with COVID-19 Using the Anti-Adrenomedullin Antibody Adrecizumab (HAM8101)Mahir Karakas, Dominik Jarczak, Martin Becker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2008
Distinct subcellular expression patterns of neutral endopeptidase (CD10) in prostate cancer predict diverging clinical courses in surgically treated patientsAchim Fleischmann, Thorsten Schlomm, Hartwig Huland, et al.
Pageof 14